Governance QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 17/06/2026 BST			5-day change	1st Jan Change
13.13 ^USD	-7.01%		-2.74%	-54.03%

05-22	QuidelOrtho Corp Voluntary Recalls Products	CI
05-07	UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating	MT

Executive Committee: QuidelOrtho Corporation

Manager

Positions heldSince

Brian Blaser

61 year

Chief Executive Officer	05/05/2024
President	05/05/2024

Joseph Busky

58 year

Comptroller/Controller/Auditor	-
Director of Finance/CFO	-

Philip McLellan

57 year

Chief Operating Officer

14/11/2024

Sergio Gadaleta

General Counsel

06/07/2025

Lisa Hayes

Public Communications Contact	-
Sales & Marketing	-

Jonathan Siegrist

Chief Tech/Sci/R&D Officer

06/10/2024

Lee Bowman

Human Resources Officer

09/09/2024

Juliet Cunningham

Investor Relations Contact

Nathaniel Sisitsky

52 year

General Counsel

22/03/2026

Composition of the Board of Directors: QuidelOrtho Corporation

Director

CommitteesSince

Kenneth Buechler

72 year

Governance Committee	10/12/2022
Nominating Committee	10/12/2022

Evelyn Dilsaver

70 year

Governance Committee	17/12/2009
Nominating Committee	17/12/2009
Audit Committee Chair	10/05/2015
Compensation Committee	12/05/2024
HR Committee	31/07/2014
Audit Committee	12/05/2024
Governance Committee Chair	12/05/2024
Nominating Committee Chair	12/05/2024

Kenneth Widder

73 year

Governance Committee Chair	31/12/2013
Nominating Committee Chair	31/12/2013
Audit Committee	01/10/2025
Governance Committee	13/06/2023
Nominating Committee	13/06/2023

R. Huennekens

62 year

Audit Committee	05/01/2025
Governance Committee	17/12/2019
Nominating Committee	17/12/2019
Compensation Committee	05/12/2024

Joseph Wilkins

64 year

Compensation Committee	31/12/2020
Governance Committee	31/12/2020
Nominating Committee	31/12/2020

Ann Rhoads

60 year

Governance Committee	31/12/2019
Nominating Committee	31/12/2019
Audit Committee Chair	31/12/2019

Mary Polan

82 year

Compensation Committee

31/12/1992

Edward Michael

68 year

Compensation Committee Chair

31/12/2017

Brian Blaser

61 year

Audit Committee Chair

11/12/2022

John Chiminski

62 year

Audit Committee

05/12/2024

Latest Appointments: QuidelOrtho Corporation

03-24	QuidelOrtho Corporation Announces Chief Legal Officer Changes	CI
02-13	Joseph M. Busky to Retire as Principal Financial Officer of Quidelortho Corporation, Effective as of June 30, 2026	CI
02-05	QuidelOrtho Corp Announces Departure of Director Matthew W. Strobeck	CI
19/08/25	Quidelortho welcomes Erich Wolff as EVP, strategy & corporate development	RE
19/08/25	QuidelOrtho Corporation Appoints Erich Wolff as Executive Vice President, Strategy & Corporate Development	CI
07/07/25	QuidelOrtho Corporation Announces Management Appointments	CI
07/07/25	Quidelortho strengthens leadership team with appointments of senior vice presidents for global quality and clinical & regulatory affairs	RE

More news

Former Officers and Directors: QuidelOrtho Corporation

Insider

Positions held

SinceUntil

Matthew Strobeck

Director/Board Member	31/12/2017	15/06/2026
Independent Dir/Board Member	31/12/2017	15/06/2026

D. Wheeler

Public Communications Contact

30/09/2023

31/03/2026

Michelle Hodges

Compliance Officer	-	-
General Counsel	30/11/2020	22/03/2026
Corporate Secretary	-	22/03/2026

Robert Schmidt

Director/Board Member	31/12/2021	20/11/2024
Independent Dir/Board Member	31/12/2021	20/11/2024

James Prutow

Director/Board Member	27/11/2023	20/11/2024
Independent Dir/Board Member	27/11/2023	20/11/2024

Robert Bujarski

Chief Operating Officer	31/08/2020	14/11/2024
General Counsel	30/06/2005	31/08/2020
President	20/02/2024	05/05/2024

Michael Iskra

Chief Executive Officer	20/02/2024	05/05/2024
Corporate Officer/Principal	05/05/2024	14/11/2024

Louise Brandy

Chief Tech/Sci/R&D Officer

30/04/2024

Patrick Klein

Chief Administrative Officer

30/04/2022

29/02/2024

Douglas Bryant

Director/Board Member	10/12/2022	20/02/2024
Chief Executive Officer	28/02/2009	20/02/2024
Chairman	28/02/2009	10/12/2022
President	10/12/2022	20/02/2024

Stephen Wise

Director/Board Member	31/12/2021	27/11/2023
Independent Dir/Board Member	31/12/2021	27/11/2023

Chris Smith

Director/Board Member

31/12/2021

30/08/2023

Werner Kroll

Chief Tech/Sci/R&D Officer

Karen Davies

Corporate Officer/Principal

Rhys de Callier

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	16
Female	4

Of which Executive Committee

Male	7
Female	2

Of which Directors

Male	8
Female	2

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.

Employees

6,500

Sector

Advanced Medical Equipment & Technology

More about the company